Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Protein Collective (TPC) is a specialist biotechnology company and contract research organization (CRO) based in Oxford, United Kingdom, dedicated to the production and engineering of high-quality recombinant proteins. Founded by industry veterans with extensive experience in structural biology and drug discovery, TPC provides tailored services including protein design, expression across mammalian, insect, and microbial systems, and sophisticated purification and characterization. The company specializes in handling challenging targets such as membrane proteins, large multi-protein complexes, and various antibody formats to support pharmaceutical and biotech research programs. By leveraging advanced technologies and deep technical expertise, The Protein Collective enables its partners to accelerate their drug discovery pipelines and structural biology projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Protein Collective.